nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—ACHE—breast cancer	0.242	0.625	CbGaD
Donepezil—CYP2D6—breast cancer	0.0782	0.202	CbGaD
Donepezil—SIGMAR1—Raloxifene—breast cancer	0.0774	0.197	CbGbCtD
Donepezil—CYP3A4—breast cancer	0.0671	0.173	CbGaD
Donepezil—SIGMAR1—Tamoxifen—breast cancer	0.0511	0.13	CbGbCtD
Donepezil—ACHE—Irinotecan—breast cancer	0.0356	0.0906	CbGbCtD
Donepezil—CYP2C9—Anastrozole—breast cancer	0.0219	0.0556	CbGbCtD
Donepezil—CYP3A4—Exemestane—breast cancer	0.0168	0.0427	CbGbCtD
Donepezil—CYP2C9—Idarubicin—breast cancer	0.0166	0.0422	CbGbCtD
Donepezil—CYP2D6—Idarubicin—breast cancer	0.0151	0.0386	CbGbCtD
Donepezil—CYP3A4—Letrozole—breast cancer	0.0143	0.0363	CbGbCtD
Donepezil—CYP3A4—Anastrozole—breast cancer	0.0127	0.0323	CbGbCtD
Donepezil—CYP3A4—Toremifene—breast cancer	0.0116	0.0296	CbGbCtD
Donepezil—CYP3A4—Fulvestrant—breast cancer	0.0108	0.0275	CbGbCtD
Donepezil—CYP3A4—Thiotepa—breast cancer	0.00963	0.0245	CbGbCtD
Donepezil—CYP2C9—Capecitabine—breast cancer	0.00908	0.0231	CbGbCtD
Donepezil—CYP3A4—Ixabepilone—breast cancer	0.00881	0.0224	CbGbCtD
Donepezil—CYP3A4—Lapatinib—breast cancer	0.00848	0.0216	CbGbCtD
Donepezil—CYP2D6—Vinorelbine—breast cancer	0.0074	0.0188	CbGbCtD
Donepezil—CYP2C9—Tamoxifen—breast cancer	0.0073	0.0186	CbGbCtD
Donepezil—CYP2D6—Tamoxifen—breast cancer	0.00668	0.017	CbGbCtD
Donepezil—CYP3A4—Raloxifene—breast cancer	0.00643	0.0164	CbGbCtD
Donepezil—CYP2C9—Paclitaxel—breast cancer	0.00568	0.0145	CbGbCtD
Donepezil—CYP2C9—Fluorouracil—breast cancer	0.00538	0.0137	CbGbCtD
Donepezil—CYP3A4—Vinorelbine—breast cancer	0.0047	0.012	CbGbCtD
Donepezil—CYP2D6—Vinblastine—breast cancer	0.00456	0.0116	CbGbCtD
Donepezil—CYP3A4—Tamoxifen—breast cancer	0.00425	0.0108	CbGbCtD
Donepezil—CYP3A4—Mitoxantrone—breast cancer	0.00414	0.0105	CbGbCtD
Donepezil—CYP3A4—Paclitaxel—breast cancer	0.0033	0.00841	CbGbCtD
Donepezil—CYP3A4—Irinotecan—breast cancer	0.00326	0.0083	CbGbCtD
Donepezil—CYP3A4—Vinblastine—breast cancer	0.0029	0.00738	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—breast cancer	0.0028	0.00713	CbGbCtD
Donepezil—CYP3A4—Docetaxel—breast cancer	0.00239	0.00608	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—breast cancer	0.00178	0.00453	CbGbCtD
Donepezil—Tetrabenazine—CYP2D6—breast cancer	0.000769	0.603	CrCbGaD
Donepezil—Doxazosin—CYP2D6—breast cancer	0.000295	0.231	CrCbGaD
Donepezil—Doxazosin—ABCB1—breast cancer	0.00021	0.165	CrCbGaD
Donepezil—Malnutrition—Methotrexate—breast cancer	2.13e-05	0.000126	CcSEcCtD
Donepezil—Erythema—Methotrexate—breast cancer	2.13e-05	0.000126	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—breast cancer	2.12e-05	0.000126	CcSEcCtD
Donepezil—Headache—Gemcitabine—breast cancer	2.12e-05	0.000126	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Capecitabine—breast cancer	2.12e-05	0.000126	CcSEcCtD
Donepezil—Vomiting—Fluorouracil—breast cancer	2.12e-05	0.000126	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—breast cancer	2.12e-05	0.000126	CcSEcCtD
Donepezil—Dyspepsia—Docetaxel—breast cancer	2.12e-05	0.000126	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—breast cancer	2.11e-05	0.000125	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—breast cancer	2.11e-05	0.000125	CcSEcCtD
Donepezil—Insomnia—Capecitabine—breast cancer	2.11e-05	0.000125	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—breast cancer	2.1e-05	0.000125	CcSEcCtD
Donepezil—Rash—Fluorouracil—breast cancer	2.1e-05	0.000125	CcSEcCtD
Donepezil—Dermatitis—Fluorouracil—breast cancer	2.1e-05	0.000125	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—breast cancer	2.1e-05	0.000125	CcSEcCtD
Donepezil—Paraesthesia—Capecitabine—breast cancer	2.09e-05	0.000124	CcSEcCtD
Donepezil—Decreased appetite—Docetaxel—breast cancer	2.09e-05	0.000124	CcSEcCtD
Donepezil—Hypersensitivity—Paclitaxel—breast cancer	2.09e-05	0.000124	CcSEcCtD
Donepezil—Headache—Fluorouracil—breast cancer	2.09e-05	0.000124	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—breast cancer	2.09e-05	0.000124	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—breast cancer	2.08e-05	0.000124	CcSEcCtD
Donepezil—Dysgeusia—Methotrexate—breast cancer	2.08e-05	0.000124	CcSEcCtD
Donepezil—Gastrointestinal disorder—Docetaxel—breast cancer	2.08e-05	0.000123	CcSEcCtD
Donepezil—Dyspnoea—Capecitabine—breast cancer	2.08e-05	0.000123	CcSEcCtD
Donepezil—Fatigue—Docetaxel—breast cancer	2.08e-05	0.000123	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—breast cancer	2.07e-05	0.000123	CcSEcCtD
Donepezil—Nausea—Mitoxantrone—breast cancer	2.07e-05	0.000123	CcSEcCtD
Donepezil—Nausea—Irinotecan—breast cancer	2.07e-05	0.000123	CcSEcCtD
Donepezil—Pain—Docetaxel—breast cancer	2.06e-05	0.000122	CcSEcCtD
Donepezil—Constipation—Docetaxel—breast cancer	2.06e-05	0.000122	CcSEcCtD
Donepezil—Back pain—Methotrexate—breast cancer	2.06e-05	0.000122	CcSEcCtD
Donepezil—Dyspepsia—Capecitabine—breast cancer	2.05e-05	0.000122	CcSEcCtD
Donepezil—Chills—Epirubicin—breast cancer	2.05e-05	0.000122	CcSEcCtD
Donepezil—Arrhythmia—Epirubicin—breast cancer	2.04e-05	0.000121	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—breast cancer	2.04e-05	0.000121	CcSEcCtD
Donepezil—Asthenia—Paclitaxel—breast cancer	2.04e-05	0.000121	CcSEcCtD
Donepezil—Decreased appetite—Capecitabine—breast cancer	2.03e-05	0.00012	CcSEcCtD
Donepezil—Alopecia—Epirubicin—breast cancer	2.02e-05	0.00012	CcSEcCtD
Donepezil—Nausea—Gemcitabine—breast cancer	2.01e-05	0.00012	CcSEcCtD
Donepezil—Gastrointestinal disorder—Capecitabine—breast cancer	2.01e-05	0.000119	CcSEcCtD
Donepezil—Fatigue—Capecitabine—breast cancer	2.01e-05	0.000119	CcSEcCtD
Donepezil—Pruritus—Paclitaxel—breast cancer	2.01e-05	0.000119	CcSEcCtD
Donepezil—Vision blurred—Methotrexate—breast cancer	2e-05	0.000119	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—breast cancer	2e-05	0.000119	CcSEcCtD
Donepezil—Constipation—Capecitabine—breast cancer	1.99e-05	0.000118	CcSEcCtD
Donepezil—Pain—Capecitabine—breast cancer	1.99e-05	0.000118	CcSEcCtD
Donepezil—Erythema—Epirubicin—breast cancer	1.99e-05	0.000118	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—breast cancer	1.99e-05	0.000118	CcSEcCtD
Donepezil—Feeling abnormal—Docetaxel—breast cancer	1.98e-05	0.000118	CcSEcCtD
Donepezil—Nausea—Fluorouracil—breast cancer	1.98e-05	0.000118	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—breast cancer	1.97e-05	0.000117	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—breast cancer	1.97e-05	0.000117	CcSEcCtD
Donepezil—Gastrointestinal pain—Docetaxel—breast cancer	1.97e-05	0.000117	CcSEcCtD
Donepezil—Anaemia—Methotrexate—breast cancer	1.96e-05	0.000117	CcSEcCtD
Donepezil—Flatulence—Epirubicin—breast cancer	1.96e-05	0.000116	CcSEcCtD
Donepezil—Tension—Epirubicin—breast cancer	1.95e-05	0.000116	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—breast cancer	1.95e-05	0.000116	CcSEcCtD
Donepezil—Diarrhoea—Paclitaxel—breast cancer	1.94e-05	0.000115	CcSEcCtD
Donepezil—Nervousness—Epirubicin—breast cancer	1.93e-05	0.000115	CcSEcCtD
Donepezil—Back pain—Epirubicin—breast cancer	1.92e-05	0.000114	CcSEcCtD
Donepezil—Feeling abnormal—Capecitabine—breast cancer	1.92e-05	0.000114	CcSEcCtD
Donepezil—Malaise—Methotrexate—breast cancer	1.92e-05	0.000114	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—breast cancer	1.91e-05	0.000114	CcSEcCtD
Donepezil—Vertigo—Methotrexate—breast cancer	1.91e-05	0.000113	CcSEcCtD
Donepezil—Gastrointestinal pain—Capecitabine—breast cancer	1.91e-05	0.000113	CcSEcCtD
Donepezil—Body temperature increased—Docetaxel—breast cancer	1.9e-05	0.000113	CcSEcCtD
Donepezil—Abdominal pain—Docetaxel—breast cancer	1.9e-05	0.000113	CcSEcCtD
Donepezil—Chills—Doxorubicin—breast cancer	1.9e-05	0.000113	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—breast cancer	1.89e-05	0.000112	CcSEcCtD
Donepezil—Dizziness—Paclitaxel—breast cancer	1.88e-05	0.000111	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—breast cancer	1.87e-05	0.000111	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—breast cancer	1.87e-05	0.000111	CcSEcCtD
Donepezil—Cough—Methotrexate—breast cancer	1.85e-05	0.00011	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—breast cancer	1.85e-05	0.00011	CcSEcCtD
Donepezil—Urticaria—Capecitabine—breast cancer	1.85e-05	0.00011	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—breast cancer	1.85e-05	0.00011	CcSEcCtD
Donepezil—Body temperature increased—Capecitabine—breast cancer	1.84e-05	0.000109	CcSEcCtD
Donepezil—Abdominal pain—Capecitabine—breast cancer	1.84e-05	0.000109	CcSEcCtD
Donepezil—Convulsion—Methotrexate—breast cancer	1.84e-05	0.000109	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Donepezil—Erythema—Doxorubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Donepezil—Anaemia—Epirubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Donepezil—Agitation—Epirubicin—breast cancer	1.83e-05	0.000109	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—breast cancer	1.81e-05	0.000108	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—breast cancer	1.81e-05	0.000107	CcSEcCtD
Donepezil—Chest pain—Methotrexate—breast cancer	1.81e-05	0.000107	CcSEcCtD
Donepezil—Myalgia—Methotrexate—breast cancer	1.81e-05	0.000107	CcSEcCtD
Donepezil—Tension—Doxorubicin—breast cancer	1.81e-05	0.000107	CcSEcCtD
Donepezil—Vomiting—Paclitaxel—breast cancer	1.81e-05	0.000107	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—breast cancer	1.8e-05	0.000107	CcSEcCtD
Donepezil—Malaise—Epirubicin—breast cancer	1.79e-05	0.000106	CcSEcCtD
Donepezil—Rash—Paclitaxel—breast cancer	1.79e-05	0.000106	CcSEcCtD
Donepezil—Dermatitis—Paclitaxel—breast cancer	1.79e-05	0.000106	CcSEcCtD
Donepezil—Discomfort—Methotrexate—breast cancer	1.79e-05	0.000106	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—breast cancer	1.79e-05	0.000106	CcSEcCtD
Donepezil—Vertigo—Epirubicin—breast cancer	1.79e-05	0.000106	CcSEcCtD
Donepezil—Syncope—Epirubicin—breast cancer	1.78e-05	0.000106	CcSEcCtD
Donepezil—Back pain—Doxorubicin—breast cancer	1.78e-05	0.000106	CcSEcCtD
Donepezil—Headache—Paclitaxel—breast cancer	1.78e-05	0.000106	CcSEcCtD
Donepezil—Hypersensitivity—Docetaxel—breast cancer	1.77e-05	0.000105	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—breast cancer	1.77e-05	0.000105	CcSEcCtD
Donepezil—Confusional state—Methotrexate—breast cancer	1.75e-05	0.000104	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—breast cancer	1.75e-05	0.000104	CcSEcCtD
Donepezil—Cough—Epirubicin—breast cancer	1.74e-05	0.000103	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—breast cancer	1.73e-05	0.000103	CcSEcCtD
Donepezil—Asthenia—Docetaxel—breast cancer	1.73e-05	0.000103	CcSEcCtD
Donepezil—Convulsion—Epirubicin—breast cancer	1.72e-05	0.000102	CcSEcCtD
Donepezil—Infection—Methotrexate—breast cancer	1.72e-05	0.000102	CcSEcCtD
Donepezil—Hypertension—Epirubicin—breast cancer	1.72e-05	0.000102	CcSEcCtD
Donepezil—Hypersensitivity—Capecitabine—breast cancer	1.72e-05	0.000102	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Donepezil—Pruritus—Docetaxel—breast cancer	1.7e-05	0.000101	CcSEcCtD
Donepezil—Nervous system disorder—Methotrexate—breast cancer	1.7e-05	0.000101	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—breast cancer	1.7e-05	0.000101	CcSEcCtD
Donepezil—Thrombocytopenia—Methotrexate—breast cancer	1.7e-05	0.000101	CcSEcCtD
Donepezil—Myalgia—Epirubicin—breast cancer	1.69e-05	0.000101	CcSEcCtD
Donepezil—Chest pain—Epirubicin—breast cancer	1.69e-05	0.000101	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—breast cancer	1.69e-05	0.000101	CcSEcCtD
Donepezil—Agitation—Doxorubicin—breast cancer	1.69e-05	0.0001	CcSEcCtD
Donepezil—Anxiety—Epirubicin—breast cancer	1.69e-05	0.0001	CcSEcCtD
Donepezil—Nausea—Paclitaxel—breast cancer	1.69e-05	0.0001	CcSEcCtD
Donepezil—Hyperhidrosis—Methotrexate—breast cancer	1.68e-05	9.95e-05	CcSEcCtD
Donepezil—Discomfort—Epirubicin—breast cancer	1.67e-05	9.93e-05	CcSEcCtD
Donepezil—Asthenia—Capecitabine—breast cancer	1.67e-05	9.92e-05	CcSEcCtD
Donepezil—Malaise—Doxorubicin—breast cancer	1.66e-05	9.85e-05	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—breast cancer	1.66e-05	9.83e-05	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—breast cancer	1.65e-05	9.82e-05	CcSEcCtD
Donepezil—Anorexia—Methotrexate—breast cancer	1.65e-05	9.82e-05	CcSEcCtD
Donepezil—Syncope—Doxorubicin—breast cancer	1.65e-05	9.8e-05	CcSEcCtD
Donepezil—Pruritus—Capecitabine—breast cancer	1.65e-05	9.79e-05	CcSEcCtD
Donepezil—Diarrhoea—Docetaxel—breast cancer	1.65e-05	9.77e-05	CcSEcCtD
Donepezil—Confusional state—Epirubicin—breast cancer	1.64e-05	9.72e-05	CcSEcCtD
Donepezil—Oedema—Epirubicin—breast cancer	1.62e-05	9.64e-05	CcSEcCtD
Donepezil—Hypotension—Methotrexate—breast cancer	1.62e-05	9.62e-05	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—breast cancer	1.62e-05	9.6e-05	CcSEcCtD
Donepezil—Infection—Epirubicin—breast cancer	1.61e-05	9.57e-05	CcSEcCtD
Donepezil—Cough—Doxorubicin—breast cancer	1.61e-05	9.53e-05	CcSEcCtD
Donepezil—Shock—Epirubicin—breast cancer	1.6e-05	9.48e-05	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—breast cancer	1.59e-05	9.47e-05	CcSEcCtD
Donepezil—Diarrhoea—Capecitabine—breast cancer	1.59e-05	9.46e-05	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—breast cancer	1.59e-05	9.45e-05	CcSEcCtD
Donepezil—Dizziness—Docetaxel—breast cancer	1.59e-05	9.45e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Epirubicin—breast cancer	1.59e-05	9.43e-05	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—breast cancer	1.59e-05	9.43e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methotrexate—breast cancer	1.58e-05	9.38e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Epirubicin—breast cancer	1.57e-05	9.32e-05	CcSEcCtD
Donepezil—Insomnia—Methotrexate—breast cancer	1.57e-05	9.31e-05	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—breast cancer	1.57e-05	9.3e-05	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—breast cancer	1.57e-05	9.3e-05	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—breast cancer	1.57e-05	9.3e-05	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—breast cancer	1.56e-05	9.27e-05	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—breast cancer	1.56e-05	9.25e-05	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—breast cancer	1.55e-05	9.19e-05	CcSEcCtD
Donepezil—Anorexia—Epirubicin—breast cancer	1.55e-05	9.19e-05	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—breast cancer	1.55e-05	9.18e-05	CcSEcCtD
Donepezil—Somnolence—Methotrexate—breast cancer	1.54e-05	9.15e-05	CcSEcCtD
Donepezil—Dizziness—Capecitabine—breast cancer	1.54e-05	9.15e-05	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—breast cancer	1.53e-05	9.1e-05	CcSEcCtD
Donepezil—Vomiting—Docetaxel—breast cancer	1.53e-05	9.08e-05	CcSEcCtD
Donepezil—Dyspepsia—Methotrexate—breast cancer	1.53e-05	9.06e-05	CcSEcCtD
Donepezil—Rash—Docetaxel—breast cancer	1.52e-05	9.01e-05	CcSEcCtD
Donepezil—Hypotension—Epirubicin—breast cancer	1.52e-05	9e-05	CcSEcCtD
Donepezil—Dermatitis—Docetaxel—breast cancer	1.52e-05	9e-05	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—breast cancer	1.51e-05	8.99e-05	CcSEcCtD
Donepezil—Decreased appetite—Methotrexate—breast cancer	1.51e-05	8.95e-05	CcSEcCtD
Donepezil—Headache—Docetaxel—breast cancer	1.51e-05	8.95e-05	CcSEcCtD
Donepezil—Oedema—Doxorubicin—breast cancer	1.5e-05	8.92e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—breast cancer	1.5e-05	8.89e-05	CcSEcCtD
Donepezil—Fatigue—Methotrexate—breast cancer	1.5e-05	8.88e-05	CcSEcCtD
Donepezil—Infection—Doxorubicin—breast cancer	1.49e-05	8.86e-05	CcSEcCtD
Donepezil—Pain—Methotrexate—breast cancer	1.48e-05	8.81e-05	CcSEcCtD
Donepezil—Vomiting—Capecitabine—breast cancer	1.48e-05	8.79e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—breast cancer	1.48e-05	8.78e-05	CcSEcCtD
Donepezil—Shock—Doxorubicin—breast cancer	1.48e-05	8.77e-05	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—breast cancer	1.47e-05	8.74e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—breast cancer	1.47e-05	8.73e-05	CcSEcCtD
Donepezil—Rash—Capecitabine—breast cancer	1.47e-05	8.72e-05	CcSEcCtD
Donepezil—Insomnia—Epirubicin—breast cancer	1.47e-05	8.72e-05	CcSEcCtD
Donepezil—Dermatitis—Capecitabine—breast cancer	1.47e-05	8.71e-05	CcSEcCtD
Donepezil—Headache—Capecitabine—breast cancer	1.46e-05	8.67e-05	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—breast cancer	1.46e-05	8.65e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—breast cancer	1.45e-05	8.62e-05	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—breast cancer	1.45e-05	8.59e-05	CcSEcCtD
Donepezil—Somnolence—Epirubicin—breast cancer	1.44e-05	8.57e-05	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—breast cancer	1.43e-05	8.5e-05	CcSEcCtD
Donepezil—Nausea—Docetaxel—breast cancer	1.43e-05	8.49e-05	CcSEcCtD
Donepezil—Feeling abnormal—Methotrexate—breast cancer	1.43e-05	8.49e-05	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—breast cancer	1.43e-05	8.48e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—breast cancer	1.42e-05	8.42e-05	CcSEcCtD
Donepezil—Decreased appetite—Epirubicin—breast cancer	1.41e-05	8.38e-05	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—breast cancer	1.4e-05	8.33e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—breast cancer	1.4e-05	8.32e-05	CcSEcCtD
Donepezil—Fatigue—Epirubicin—breast cancer	1.4e-05	8.31e-05	CcSEcCtD
Donepezil—Constipation—Epirubicin—breast cancer	1.39e-05	8.24e-05	CcSEcCtD
Donepezil—Pain—Epirubicin—breast cancer	1.39e-05	8.24e-05	CcSEcCtD
Donepezil—Nausea—Capecitabine—breast cancer	1.38e-05	8.22e-05	CcSEcCtD
Donepezil—Urticaria—Methotrexate—breast cancer	1.38e-05	8.18e-05	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—breast cancer	1.37e-05	8.14e-05	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—breast cancer	1.37e-05	8.14e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.37e-05	8.12e-05	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—breast cancer	1.36e-05	8.06e-05	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—breast cancer	1.35e-05	8.01e-05	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—breast cancer	1.34e-05	7.95e-05	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—breast cancer	1.34e-05	7.94e-05	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—breast cancer	1.34e-05	7.93e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—breast cancer	1.33e-05	7.88e-05	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—breast cancer	1.32e-05	7.85e-05	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—breast cancer	1.31e-05	7.75e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—breast cancer	1.3e-05	7.7e-05	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—breast cancer	1.3e-05	7.69e-05	CcSEcCtD
Donepezil—Urticaria—Epirubicin—breast cancer	1.29e-05	7.66e-05	CcSEcCtD
Donepezil—Pain—Doxorubicin—breast cancer	1.28e-05	7.62e-05	CcSEcCtD
Donepezil—Constipation—Doxorubicin—breast cancer	1.28e-05	7.62e-05	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—breast cancer	1.28e-05	7.62e-05	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—breast cancer	1.28e-05	7.62e-05	CcSEcCtD
Donepezil—Hypersensitivity—Methotrexate—breast cancer	1.28e-05	7.59e-05	CcSEcCtD
Donepezil—Asthenia—Methotrexate—breast cancer	1.24e-05	7.39e-05	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—breast cancer	1.24e-05	7.35e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—breast cancer	1.23e-05	7.29e-05	CcSEcCtD
Donepezil—Pruritus—Methotrexate—breast cancer	1.23e-05	7.29e-05	CcSEcCtD
Donepezil—Hypersensitivity—Epirubicin—breast cancer	1.2e-05	7.1e-05	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—breast cancer	1.19e-05	7.08e-05	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—breast cancer	1.19e-05	7.05e-05	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—breast cancer	1.19e-05	7.05e-05	CcSEcCtD
Donepezil—Diarrhoea—Methotrexate—breast cancer	1.19e-05	7.05e-05	CcSEcCtD
Donepezil—Asthenia—Epirubicin—breast cancer	1.16e-05	6.91e-05	CcSEcCtD
Donepezil—Pruritus—Epirubicin—breast cancer	1.15e-05	6.82e-05	CcSEcCtD
Donepezil—Dizziness—Methotrexate—breast cancer	1.15e-05	6.81e-05	CcSEcCtD
Donepezil—Diarrhoea—Epirubicin—breast cancer	1.11e-05	6.59e-05	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—breast cancer	1.11e-05	6.57e-05	CcSEcCtD
Donepezil—Vomiting—Methotrexate—breast cancer	1.1e-05	6.55e-05	CcSEcCtD
Donepezil—Rash—Methotrexate—breast cancer	1.09e-05	6.49e-05	CcSEcCtD
Donepezil—Dermatitis—Methotrexate—breast cancer	1.09e-05	6.49e-05	CcSEcCtD
Donepezil—Headache—Methotrexate—breast cancer	1.09e-05	6.45e-05	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—breast cancer	1.08e-05	6.4e-05	CcSEcCtD
Donepezil—Dizziness—Epirubicin—breast cancer	1.07e-05	6.37e-05	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—breast cancer	1.06e-05	6.31e-05	CcSEcCtD
Donepezil—Vomiting—Epirubicin—breast cancer	1.03e-05	6.13e-05	CcSEcCtD
Donepezil—Nausea—Methotrexate—breast cancer	1.03e-05	6.12e-05	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—breast cancer	1.03e-05	6.1e-05	CcSEcCtD
Donepezil—Rash—Epirubicin—breast cancer	1.02e-05	6.08e-05	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—breast cancer	1.02e-05	6.07e-05	CcSEcCtD
Donepezil—Headache—Epirubicin—breast cancer	1.02e-05	6.04e-05	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—breast cancer	9.93e-06	5.9e-05	CcSEcCtD
Donepezil—Nausea—Epirubicin—breast cancer	9.64e-06	5.72e-05	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—breast cancer	9.55e-06	5.67e-05	CcSEcCtD
Donepezil—Rash—Doxorubicin—breast cancer	9.47e-06	5.62e-05	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—breast cancer	9.46e-06	5.62e-05	CcSEcCtD
Donepezil—Headache—Doxorubicin—breast cancer	9.41e-06	5.59e-05	CcSEcCtD
Donepezil—Nausea—Doxorubicin—breast cancer	8.92e-06	5.3e-05	CcSEcCtD
Donepezil—CYP2C9—Metabolism—HBA1—breast cancer	4.62e-06	9.28e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—breast cancer	4.61e-06	9.26e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—breast cancer	4.55e-06	9.14e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—breast cancer	4.55e-06	9.14e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ACHE—breast cancer	4.55e-06	9.14e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—breast cancer	4.51e-06	9.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFA—breast cancer	4.51e-06	9.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMMR—breast cancer	4.51e-06	9.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA3—breast cancer	4.51e-06	9.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCC1—breast cancer	4.51e-06	9.06e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—breast cancer	4.51e-06	9.06e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ACHE—breast cancer	4.51e-06	9.06e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFBR2—breast cancer	4.45e-06	8.93e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ITPR1—breast cancer	4.37e-06	8.79e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.37e-06	8.78e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—breast cancer	4.35e-06	8.75e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP3—breast cancer	4.34e-06	8.73e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB4—breast cancer	4.34e-06	8.73e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT5A—breast cancer	4.34e-06	8.73e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—breast cancer	4.33e-06	8.71e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP17A1—breast cancer	4.3e-06	8.65e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—breast cancer	4.28e-06	8.6e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP17A1—breast cancer	4.27e-06	8.57e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO1—breast cancer	4.26e-06	8.56e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS1—breast cancer	4.26e-06	8.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO1—breast cancer	4.22e-06	8.49e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS1—breast cancer	4.22e-06	8.49e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.21e-06	8.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SMAD4—breast cancer	4.21e-06	8.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1R—breast cancer	4.18e-06	8.4e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—breast cancer	4.16e-06	8.37e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.15e-06	8.35e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2D6—breast cancer	4.14e-06	8.32e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—breast cancer	4.14e-06	8.32e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA9—breast cancer	4.12e-06	8.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA4—breast cancer	4.12e-06	8.29e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HES1—breast cancer	4.11e-06	8.26e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOA2—breast cancer	4.1e-06	8.24e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLA2G4A—breast cancer	4.08e-06	8.21e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NCOR1—breast cancer	4.08e-06	8.21e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOA2—breast cancer	4.07e-06	8.17e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CSF2—breast cancer	4.04e-06	8.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF1—breast cancer	4.04e-06	8.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAF1—breast cancer	4.03e-06	8.1e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX2—breast cancer	4.02e-06	8.08e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA2—breast cancer	4.02e-06	8.08e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—breast cancer	4.02e-06	8.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRG1—breast cancer	4.01e-06	8.06e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—H2AFX—breast cancer	3.98e-06	8e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—breast cancer	3.98e-06	8e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—breast cancer	3.98e-06	8e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FASN—breast cancer	3.98e-06	7.99e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX4—breast cancer	3.97e-06	7.98e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SULT1A1—breast cancer	3.97e-06	7.98e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCHE—breast cancer	3.96e-06	7.96e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—breast cancer	3.96e-06	7.96e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—E2F1—breast cancer	3.95e-06	7.94e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FASN—breast cancer	3.94e-06	7.92e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—breast cancer	3.93e-06	7.91e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCHE—breast cancer	3.93e-06	7.89e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC5A5—breast cancer	3.91e-06	7.86e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC5A5—breast cancer	3.88e-06	7.79e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA1—breast cancer	3.88e-06	7.79e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—IDH1—breast cancer	3.88e-06	7.79e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NAT2—breast cancer	3.83e-06	7.7e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SPP1—breast cancer	3.8e-06	7.63e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—breast cancer	3.79e-06	7.62e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—breast cancer	3.78e-06	7.6e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A1—breast cancer	3.78e-06	7.59e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NQO1—breast cancer	3.78e-06	7.59e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB3—breast cancer	3.76e-06	7.55e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGFR2—breast cancer	3.75e-06	7.54e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A1—breast cancer	3.75e-06	7.53e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NQO1—breast cancer	3.75e-06	7.53e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP3A4—breast cancer	3.68e-06	7.41e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.67e-06	7.37e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP3A4—breast cancer	3.65e-06	7.34e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.63e-06	7.3e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1B1—breast cancer	3.62e-06	7.28e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—breast cancer	3.61e-06	7.26e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—breast cancer	3.6e-06	7.23e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1B1—breast cancer	3.59e-06	7.22e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.55e-06	7.14e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.52e-06	7.08e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—breast cancer	3.5e-06	7.03e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGFR1—breast cancer	3.5e-06	7.02e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—breast cancer	3.47e-06	6.98e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOA1—breast cancer	3.46e-06	6.95e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—breast cancer	3.44e-06	6.92e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOA1—breast cancer	3.43e-06	6.89e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—STK11—breast cancer	3.41e-06	6.84e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP19A1—breast cancer	3.41e-06	6.84e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—STK11—breast cancer	3.38e-06	6.79e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP19A1—breast cancer	3.38e-06	6.79e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MED12—breast cancer	3.36e-06	6.76e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DPYD—breast cancer	3.36e-06	6.76e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LEP—breast cancer	3.36e-06	6.75e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CAV1—breast cancer	3.33e-06	6.69e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDOA—breast cancer	3.31e-06	6.65e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—breast cancer	3.29e-06	6.62e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOA3—breast cancer	3.21e-06	6.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—breast cancer	3.21e-06	6.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A2—breast cancer	3.19e-06	6.41e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.17e-06	6.37e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FN1—breast cancer	3.17e-06	6.37e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—COMT—breast cancer	3.17e-06	6.36e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—breast cancer	3.15e-06	6.33e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—COMT—breast cancer	3.14e-06	6.31e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NFKBIA—breast cancer	3.13e-06	6.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CPT1A—breast cancer	3.13e-06	6.28e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTR—breast cancer	3.13e-06	6.28e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG2—breast cancer	3.13e-06	6.28e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—breast cancer	3.12e-06	6.28e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—breast cancer	3.11e-06	6.25e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH1—breast cancer	3.1e-06	6.23e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ITPR1—breast cancer	3.1e-06	6.23e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—breast cancer	3.08e-06	6.19e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ITPR1—breast cancer	3.07e-06	6.18e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HPGDS—breast cancer	3.06e-06	6.16e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HBA1—breast cancer	3.05e-06	6.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KIT—breast cancer	3.03e-06	6.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—breast cancer	3.03e-06	6.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APC—breast cancer	3.03e-06	6.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGF—breast cancer	3e-06	6.03e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—breast cancer	2.98e-06	6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ACHE—breast cancer	2.97e-06	5.97e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—breast cancer	2.97e-06	5.97e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—breast cancer	2.96e-06	5.94e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMS—breast cancer	2.93e-06	5.89e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK3—breast cancer	2.9e-06	5.84e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMS—breast cancer	2.9e-06	5.84e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—breast cancer	2.9e-06	5.82e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.9e-06	5.82e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOR1—breast cancer	2.9e-06	5.82e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—breast cancer	2.87e-06	5.77e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOR1—breast cancer	2.87e-06	5.77e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.87e-06	5.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BRAF—breast cancer	2.85e-06	5.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP17A1—breast cancer	2.81e-06	5.65e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO1—breast cancer	2.79e-06	5.6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS1—breast cancer	2.79e-06	5.6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1—breast cancer	2.78e-06	5.58e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT2—breast cancer	2.78e-06	5.58e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—breast cancer	2.77e-06	5.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—breast cancer	2.76e-06	5.55e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—breast cancer	2.75e-06	5.53e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A1—breast cancer	2.75e-06	5.52e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2D6—breast cancer	2.73e-06	5.49e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ERCC2—breast cancer	2.72e-06	5.47e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A1—breast cancer	2.72e-06	5.47e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ERCC2—breast cancer	2.7e-06	5.42e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOA2—breast cancer	2.68e-06	5.39e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—breast cancer	2.67e-06	5.36e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	2.64e-06	5.31e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SERPINE1—breast cancer	2.64e-06	5.3e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—breast cancer	2.61e-06	5.25e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FASN—breast cancer	2.6e-06	5.23e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCHE—breast cancer	2.59e-06	5.2e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—breast cancer	2.56e-06	5.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC5A5—breast cancer	2.56e-06	5.14e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—breast cancer	2.54e-06	5.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—breast cancer	2.52e-06	5.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A1—breast cancer	2.47e-06	4.96e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NQO1—breast cancer	2.47e-06	4.96e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—breast cancer	2.45e-06	4.92e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	2.4e-06	4.82e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MDM2—breast cancer	2.39e-06	4.8e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAF1—breast cancer	2.38e-06	4.78e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RELA—breast cancer	2.37e-06	4.76e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1B1—breast cancer	2.37e-06	4.76e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAV1—breast cancer	2.36e-06	4.74e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—breast cancer	2.36e-06	4.73e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAV1—breast cancer	2.34e-06	4.7e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—breast cancer	2.32e-06	4.67e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—breast cancer	2.32e-06	4.67e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.32e-06	4.67e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOA1—breast cancer	2.26e-06	4.54e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.24e-06	4.49e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—breast cancer	2.23e-06	4.49e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—STK11—breast cancer	2.23e-06	4.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP19A1—breast cancer	2.23e-06	4.48e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—breast cancer	2.22e-06	4.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1B—breast cancer	2.18e-06	4.38e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—breast cancer	2.16e-06	4.34e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—breast cancer	2.15e-06	4.32e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—breast cancer	2.14e-06	4.3e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—breast cancer	2.13e-06	4.29e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—breast cancer	2.13e-06	4.28e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—breast cancer	2.12e-06	4.27e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—breast cancer	2.08e-06	4.18e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUN—breast cancer	2.08e-06	4.17e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COMT—breast cancer	2.07e-06	4.16e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.06e-06	4.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—breast cancer	2.06e-06	4.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—breast cancer	2.03e-06	4.08e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ITPR1—breast cancer	2.03e-06	4.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—breast cancer	2.02e-06	4.06e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.01e-06	4.05e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—breast cancer	2.01e-06	4.04e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—breast cancer	2e-06	4.02e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.96e-06	3.95e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.96e-06	3.94e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—breast cancer	1.95e-06	3.92e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMS—breast cancer	1.92e-06	3.85e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOR1—breast cancer	1.89e-06	3.81e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.89e-06	3.81e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—breast cancer	1.89e-06	3.81e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—breast cancer	1.89e-06	3.8e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—breast cancer	1.87e-06	3.77e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—breast cancer	1.87e-06	3.75e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—breast cancer	1.86e-06	3.74e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—breast cancer	1.85e-06	3.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.81e-06	3.65e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—breast cancer	1.81e-06	3.64e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—breast cancer	1.8e-06	3.61e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A1—breast cancer	1.79e-06	3.61e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—breast cancer	1.79e-06	3.59e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ERCC2—breast cancer	1.78e-06	3.58e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—breast cancer	1.77e-06	3.56e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.72e-06	3.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—breast cancer	1.67e-06	3.36e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—breast cancer	1.67e-06	3.35e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.66e-06	3.35e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—breast cancer	1.65e-06	3.31e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—breast cancer	1.63e-06	3.28e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—breast cancer	1.63e-06	3.28e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—breast cancer	1.63e-06	3.28e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—breast cancer	1.62e-06	3.25e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAV1—breast cancer	1.54e-06	3.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—breast cancer	1.54e-06	3.1e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—breast cancer	1.42e-06	2.86e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.42e-06	2.85e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—breast cancer	1.41e-06	2.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—breast cancer	1.41e-06	2.83e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—breast cancer	1.37e-06	2.75e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—breast cancer	1.31e-06	2.63e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—breast cancer	1.25e-06	2.52e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—breast cancer	1.24e-06	2.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—breast cancer	1.22e-06	2.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—breast cancer	1.17e-06	2.35e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—breast cancer	1.16e-06	2.33e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—breast cancer	1.08e-06	2.17e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—breast cancer	1.07e-06	2.15e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—breast cancer	1e-06	2.02e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—breast cancer	9.96e-07	2e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—breast cancer	9.31e-07	1.87e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—breast cancer	8.21e-07	1.65e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—breast cancer	8.13e-07	1.63e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—breast cancer	6.57e-07	1.32e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—breast cancer	5.37e-07	1.08e-05	CbGpPWpGaD
